X

LLY

Eli Lilly and Company (LLY) Lilly To Acquire Orna Therapeutics To Advance Cell Therapies

Eli Lilly and Company (NYSE: LLY) FY 2026 Other Release

Eli Lilly and Company (LLY) Q4 2025 Earnings Call

Eli Lilly and Company (NYSE: LLY) Q4 2025 Earnings Conference

Key highlights from Eli Lilly’s (LLY) Q4 2025 earnings results

Eli Lilly and Company (NYSE: LLY) reported its fourth quarter 2025 earnings results today. Revenue increased 43% year-over-year to $19.3 billion.…

Eli Lilly and Company (LLY) Q2 2025 Earnings Call Transcript

Eli Lilly and Company (NYSE: LLY) Q2 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Mike Czapar — Investor…

Eli Lilly and Company (LLY) Q3 2025 Earnings Call Transcript

Eli Lilly and Company (NYSE: LLY) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Mike Czapar — Senior…

Eli Lilly (LLY) Earnings: 3Q25 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported its third quarter 2025 earnings results today. Worldwide revenue was $17.60 billion, up…

Key highlights from Eli Lilly’s (LLY) Q2 2025 earnings results

Eli Lilly and Company (NYSE: LLY) reported its second quarter 2025 earnings results today. Worldwide revenue was $15.56 billion, up…

Eli Lilly (LLY) set to report Q2 2025 results. Here’s what to expect

Eli Lilly and Company (NYSE: LLY) had a positive start to fiscal 2025, reporting strong revenue and earnings growth for…

Infographic: How Eli Lilly (LLY) performed in Q1 2025

Eli Lilly and Company (NYSE: LLY) reported its first quarter 2025 earnings results today. Worldwide revenue was $12.73 billion, up…

Eli Lilly (LLY) Q3 2024 Earnings: Key financials and quarterly highlights

Eli Lilly and Company (NYSE: LLY) reported its third quarter 2024 earnings results today. Worldwide revenue was $11.44 billion, up…